Atlas Trials

Efalizumab in the Treatment of Alopecia, Phase II

Clinical trial NCT00746980 · WITHDRAWN

Trial details

NCT number
NCT00746980
Sponsor
Northwestern University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Alopecia Totalis
Start date
2008-08-01
Primary completion
2009-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.